NCT02921308

Brief Summary

Health Issue: Bronchopulmonary dysplasia (BPD), a chronic lung disease, is the most common complication of being born premature. Damage to the still developing lung stops the normal formation of the alveoli. Young adults with a history of BPD have lower lung function, early heart disease, and increased risk of death, compared to those without BPD. Recently, it has been reported that they may also develop a type of lung disease typically seen in older adults with a longstanding history of smoking. The severity of lung disease is usually measured using pulmonary function tests (PFT), but these tests may be normal, even in the presence of important changes in the fine structure of the lung. Such structural changes may be early markers of future lung disease and can be detected using lung magnetic resonance imaging (MRI). Unlike other ways of imaging the lungs, MRI does not expose people to harmful X-rays. To date, no studies have been done to examine the fine structure of the lung of school-aged children who had a history of BPD, to determine whether there are signs of lung disease that might not otherwise be obvious. This is important because once armed with this information, preventive measures can be taken to avoid worsening of lung disease. Objective: 1) In 7-9 year-old children born extremely premature, lung MRI will be compared between those with and without BPD. The Investigators expect to observe more severe structural lung abnormalities in children with BPD, compared to those without BPD; 2) The Investigators will test to see if children with more severe MRI abnormalities also have worse lung function, and/or more symptoms of breathing problems. The Investigators expect to observe more PFT abnormalities in children with BPD than in those without and that these will match up with lung fine structure abnormalities identified on MRI. How will work be undertaken? Children 7-9 years old who were born extremely prematurely will be recruited to participate in this study. Participants will be identified from Neonatal Follow-up clinics they attended. The Investigators will enroll 20 children with BPD and 20 without BPD. Participants will have lung MR images taken, during which they need to lie still for a few minutes. PFT will also be performed, during which they will blow into a machine. Parents will be asked to complete questionnaires about breathing problems, their living conditions (environment) and any doctor visits or hospital stays. Medical charts will be reviewed for information about their birth. Unique/Innovative Aspects: This will be the first study using MRI as an innovative way to visualize and measure fine structure of the lung in children born prematurely with and without BPD. These findings may be early markers of lung disease, which would identify children who have, or are at risk of developing lung disease later in life, for whom the Investigators may be able to offer treatments now and/or prevent worsening of lung disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 3, 2016

Completed
1.3 years until next milestone

Study Start

First participant enrolled

January 5, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 18, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 18, 2019

Completed
Last Updated

July 31, 2020

Status Verified

July 1, 2020

Enrollment Period

1.7 years

First QC Date

August 18, 2016

Last Update Submit

July 29, 2020

Conditions

Keywords

PrematurityBronchopulmonary dysplasiaMRIPFTEmphysema

Outcome Measures

Primary Outcomes (1)

  • Primary Outcome: MRI-derived Pulmonary Microstructure measurements

    Images will be acquired in 10-15 seconds in all subjects using a 2D radial ultra-short echo time pulse sequence, to quantify signal intensity as a surrogate of parenchymal tissue density. Subjects will be asked to breath normally and then inhale a fixed volume of air from functional residual capacity (the volume of which is calibrated to 50% of inspiratory capacity) and hold their breath while images are acquired, as previously described. The pulse sequence for imaging will be developed as previously described and validated for the different MR scanner platforms at the three participating sites, through the Imaging platform of the Canadian Respiratory Research Network. All image volumes will be scaled to functional residual capacity plus 50% of inspiratory capacity and will be acquired in breath-hold at that inspiratory volume. The CRRN Imaging platform will also provide test objects for calibration of 1H MRI signal intensity to ensure

    Assessed at one time point at Baseline

Secondary Outcomes (16)

  • Height

    Assessed at one time point at Baseline

  • Weight

    Assessed at one time point at Baseline

  • Airflow limitations

    Assessed at one time point at Baseline

  • Airflow limitations

    Assessed at one time point at Baseline

  • Airflow limitations

    Assessed at one time point at Baseline

  • +11 more secondary outcomes

Study Arms (2)

With BPD

No intervention will be administered. After informed consent is obtained, children will undergo ultra-short echo time pulmonary MRI, followed by PFT and completion of questionnaires.

Without BPD

No intervention will be administered. After informed consent is obtained, children will undergo ultra-short echo time pulmonary MRI, followed by PFT and completion of questionnaires.

Eligibility Criteria

Age7 Years - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children born pre-term at less than 28 weeks' gestation, currently aged 7-9 years, with and without BPD will be included. BPD will be defined as need for oxygen at 36 weeks' postmenstrual age,2 which includes those with moderate-severe disease.47 Children 7-9 years of age were selected in order to include the youngest age at which pulmonary function, including lung volumes and single breath pulmonary diffusing capacity for carbon monoxide, can routinely be reliably measured using methods that require subject cooperation.

You may not qualify if:

  • Children with known interstitial lung disease, congenital lung anomalies, cystic fibrosis, ciliary dysfunction, immunodeficiency, neuromuscular disease or structural heart disease, which may have associated PFT and/or MRI findings;
  • Genetic syndromes which may have other associated structural lung anomalies;
  • Any contraindications for MRI;
  • Severe neurosensory deficits which would prevent test completion;
  • Viral or bacterial respiratory infection within 6 weeks.50

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Children's Hospital of Eastern Ontario

Ottawa, Ontario, K1H 8L1, Canada

Location

The Children"s Hospital of Eastern Ontario

Ottawa, Ontario, K1H 8L1, Canada

Location

Hospital for Sick Children

Toronto, Ontario, M5G 1X8, Canada

Location

CHU-Sainte Justine

Montreal, Quebec, H3T 1C5, Canada

Location

Related Publications (1)

  • Katz SL, Parraga G, Luu TM, Santyr G, Abdeen N, Deschenes S, Tse SM, Couch MJ, Barrowman N, Hayawi L, Momoli F, Blinder H, Thebaud B, Nuyt AM, Ben Fadel N, Moraes TJ. Pulmonary Magnetic Resonance Imaging of Ex-Preterm Children with and without Bronchopulmonary Dysplasia. Ann Am Thorac Soc. 2022 Jul;19(7):1149-1157. doi: 10.1513/AnnalsATS.202106-691OC.

MeSH Terms

Conditions

Bronchopulmonary DysplasiaPremature BirthEmphysema

Condition Hierarchy (Ancestors)

Ventilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sherri Katz

    Children's Hospital of Eastern Ontario

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Respirologist

Study Record Dates

First Submitted

August 18, 2016

First Posted

October 3, 2016

Study Start

January 5, 2018

Primary Completion

September 18, 2019

Study Completion

September 18, 2019

Last Updated

July 31, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations